Skip to main content
Top
Published in: Clinical Rheumatology 1/2021

01-01-2021 | Pulmonary-Function Tests | Brief Report

Longitudinal change during follow-up of systemic sclerosis: correlation between high-resolution computed tomography and pulmonary function tests

Authors: Aldo Carnevale, Mario Silva, Elisa Maietti, Gianluca Milanese, Marta Saracco, Simone Parisi, Elena Bravi, Fabio De Gennaro, Eugenio Arrigoni, Flavio Cesare Bodini, Enrico Fusaro, Carlo Alberto Scirè, Nicola Sverzellati, Alarico Ariani

Published in: Clinical Rheumatology | Issue 1/2021

Login to get access

Abstract

The objective of this study was to determine the correlation between functional and radiological longitudinal change in patients with systemic sclerosis–associated interstitial lung disease (SSc-ILD), and to test the OMERACT definition of clinically meaningful progression of pulmonary function tests (PFTs) for the prediction of ILD radiological evolution. We retrospectively retrieved high-resolution computed tomography (HRCT) studies and PFTs including DLco, both available at two time-points and performed within 6 months of each other, in SSc patients. A subset of patients was selected using a 12–24-month clinically oriented interval (n = 58). The extent of ILD at HRCT was scored according to a visual semi-quantitative method (SQCT). The correlation of absolute change (Δ) in the SQCT score with change in FVC and DLco was examined using Pearson’s correlation coefficient. The concordance between the OMERACT criteria (≥ 10% FVC relative decline; or 5–10% FVC and ≥ 15% DLco relative decline) and SQCT categorical change (5% and 10%) was investigated. A total of 129 patients were enrolled. During 12–24-month follow-up, ΔSQCT was negatively correlated with ΔFVC (r = − 0.487, p = 0.0001) and ΔDLco (r = − 0.298, p = 0.023). Ten patients demonstrated CT progression ΔSQCT > 5%, among whom 5 with ΔSQCT > 10%. OMERACT criteria identified 25 patients with progressive SSc-ILD, of whom only 5 presented ΔSQCT > 5 and 3 presented ΔSQCT > 10%. In conclusion, change in radiological extent of SSc-ILD was correlated to functional decline in a limited time-frame. Repeated HRCT after 12–24 months may be useful for the longitudinal characterization of ILD evolution in patients with stable pulmonary function. Conversely, functional changes are suggestive of a concurrent radiological progression only after this interval.
Key Points
• In SSc patients, chest HRCT performed every 12–24 months can detect minimal but significant changes in ILD extent, even in subjects with stable pulmonary function.
• PFT changes in 12–24 months are related to the radiological ILD progression.
• OMERACT criteria might overlook patients with radiological progression.
• Repeated chest HRCT may be useful for monitoring SSc-ILD when performed within 12 to 24 months from baseline in order to promptly detect progression and possibly impact on prognosis.
Appendix
Available only for authorised users
Literature
5.
go back to reference Sverzellati N, Silva M, Seletti V, Galeone C, Palmucci S, Piciucchi S, Vancheri C, Poletti V, Tomassetti S, Karwoski R, Bartholmai BJ (2020) Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity. Eur Radiol 30:2669–2679. https://doi.org/10.1007/s00330-019-06619-5CrossRefPubMed Sverzellati N, Silva M, Seletti V, Galeone C, Palmucci S, Piciucchi S, Vancheri C, Poletti V, Tomassetti S, Karwoski R, Bartholmai BJ (2020) Stratification of long-term outcome in stable idiopathic pulmonary fibrosis by combining longitudinal computed tomography and forced vital capacity. Eur Radiol 30:2669–2679. https://​doi.​org/​10.​1007/​s00330-019-06619-5CrossRefPubMed
9.
go back to reference Ariani A, Silva M, Bravi E, Parisi S, Saracco M, de Gennaro F, Caimmi C, Girelli F, de Santis M, Volpe A, Lumetti F, Hax V, Bredemeier M, Alfieri V, Santilli D, Bodini FC, Lucchini G, Mozzani F, Seletti V, Bacchini E, Arrigoni E, Giuggioli D, Chakr R, Idolazzi L, Bertorelli G, Imberti D, Michieletti E, Paolazzi G, Fusaro E, Chetta AA, Scirè CA, Sverzellati N (2019) Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis. RMD Open 5:e000820. https://doi.org/10.1136/rmdopen-2018-000820CrossRefPubMedPubMedCentral Ariani A, Silva M, Bravi E, Parisi S, Saracco M, de Gennaro F, Caimmi C, Girelli F, de Santis M, Volpe A, Lumetti F, Hax V, Bredemeier M, Alfieri V, Santilli D, Bodini FC, Lucchini G, Mozzani F, Seletti V, Bacchini E, Arrigoni E, Giuggioli D, Chakr R, Idolazzi L, Bertorelli G, Imberti D, Michieletti E, Paolazzi G, Fusaro E, Chetta AA, Scirè CA, Sverzellati N (2019) Overall mortality in combined pulmonary fibrosis and emphysema related to systemic sclerosis. RMD Open 5:e000820. https://​doi.​org/​10.​1136/​rmdopen-2018-000820CrossRefPubMedPubMedCentral
10.
go back to reference Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165:1581–1586. https://doi.org/10.1164/rccm.2106012CrossRefPubMed Bouros D, Wells AU, Nicholson AG, Colby TV, Polychronopoulos V, Pantelidis P, Haslam PL, Vassilakis DA, Black CM, du Bois RM (2002) Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 165:1581–1586. https://​doi.​org/​10.​1164/​rccm.​2106012CrossRefPubMed
12.
go back to reference Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TDL, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O (2015) Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 67:3256–3261. https://doi.org/10.1002/art.39405CrossRefPubMed Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TDL, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O (2015) Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 67:3256–3261. https://​doi.​org/​10.​1002/​art.​39405CrossRefPubMed
15.
go back to reference Ariani A, Silva M, Bravi E, Saracco M, Parisi S, de Gennaro F, Lumetti F, Idolazzi L, Seletti V, Caramaschi P, Benini C, Bodini FC, Scirè CA, Lucchini G, Santilli D, Mozzani F, Imberti D, Arrigoni E, Delsante G, Pellerito R, Fusaro E, Sverzellati N (2015) Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: a multi-centric study. Mod Rheumatol 25:724–730. https://doi.org/10.3109/14397595.2015.1016200CrossRefPubMed Ariani A, Silva M, Bravi E, Saracco M, Parisi S, de Gennaro F, Lumetti F, Idolazzi L, Seletti V, Caramaschi P, Benini C, Bodini FC, Scirè CA, Lucchini G, Santilli D, Mozzani F, Imberti D, Arrigoni E, Delsante G, Pellerito R, Fusaro E, Sverzellati N (2015) Operator-independent quantitative chest computed tomography versus standard assessment of interstitial lung disease related to systemic sclerosis: a multi-centric study. Mod Rheumatol 25:724–730. https://​doi.​org/​10.​3109/​14397595.​2015.​1016200CrossRefPubMed
18.
go back to reference Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TDL, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O (2015) Pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 67:3256–3261. https://doi.org/10.1002/art.39405CrossRefPubMed Suliman YA, Dobrota R, Huscher D, Nguyen-Kim TDL, Maurer B, Jordan S, Speich R, Frauenfelder T, Distler O (2015) Pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease. Arthritis Rheumatol 67:3256–3261. https://​doi.​org/​10.​1002/​art.​39405CrossRefPubMed
19.
go back to reference Hoffmann-Vold AM, Aaløkken TM, Lund MB, Garen T, Midtvedt Ø, Brunborg C, Gran JT, Molberg Ø (2015) Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis. Arthritis Rheumatol 67:2205–2212. https://doi.org/10.1002/art.39166CrossRefPubMed Hoffmann-Vold AM, Aaløkken TM, Lund MB, Garen T, Midtvedt Ø, Brunborg C, Gran JT, Molberg Ø (2015) Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis. Arthritis Rheumatol 67:2205–2212. https://​doi.​org/​10.​1002/​art.​39166CrossRefPubMed
21.
go back to reference Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, Byron J, Sahhar J, Roddy J, Gabbay E, Youssef P, Nash P, Zochling J, Proudman SM, Stevens W, Nikpour M (2013) Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford) 52:155–160. https://doi.org/10.1093/rheumatology/kes289CrossRef Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, Byron J, Sahhar J, Roddy J, Gabbay E, Youssef P, Nash P, Zochling J, Proudman SM, Stevens W, Nikpour M (2013) Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Rheumatology (Oxford) 52:155–160. https://​doi.​org/​10.​1093/​rheumatology/​kes289CrossRef
22.
25.
go back to reference Moore OA, Proudman SM, Goh N, Corte TJ, Rouse H, Hennessy O, Morrisroe K, Thakkar V, Sahhar J, Roddy J, Youssef P, Gabbay E, Nash P, Zochling J, Stevens W, Nikpour M (2015) Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clin Exp Rheumatol 33:S111–S116PubMed Moore OA, Proudman SM, Goh N, Corte TJ, Rouse H, Hennessy O, Morrisroe K, Thakkar V, Sahhar J, Roddy J, Youssef P, Gabbay E, Nash P, Zochling J, Stevens W, Nikpour M (2015) Quantifying change in pulmonary function as a prognostic marker in systemic sclerosis-related interstitial lung disease. Clin Exp Rheumatol 33:S111–S116PubMed
Metadata
Title
Longitudinal change during follow-up of systemic sclerosis: correlation between high-resolution computed tomography and pulmonary function tests
Authors
Aldo Carnevale
Mario Silva
Elisa Maietti
Gianluca Milanese
Marta Saracco
Simone Parisi
Elena Bravi
Fabio De Gennaro
Eugenio Arrigoni
Flavio Cesare Bodini
Enrico Fusaro
Carlo Alberto Scirè
Nicola Sverzellati
Alarico Ariani
Publication date
01-01-2021
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 1/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05375-y

Other articles of this Issue 1/2021

Clinical Rheumatology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.